Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Prolymphocytic 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Leukemia 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Blast Crisis 1

Interventions

Rituximab 5Cyclophosphamide 4fludarabine phosphate 3alvocidib 3Peripheral Blood Stem Cell Transplantation 3Sunitinib 2Pharmacogenomic Testing 2Lenalidomide 2Filgrastim 2Carboplatin 2tanespimycin 1sargramostim 1ofatumumab 1obatoclax 1laromustine 1dinaciclib 1cytokine inducible SH2-containing protein 1Vorinostat 1Vincristine 1Therapeutics 1Tacrolimus 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Psychiatric Rehabilitation 1Prednisone 1Polymerase Chain Reaction 1Pentostatin 1Mycophenolic Acid 1Microarray Analysis 1Methotrexate 1MK 2206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Prolymphocytic × obatoclax × Clear all
NCT00612612 2013-09-30

Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
28 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡